Fei (FEIC) 10-Q 2 May 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 30, 2014	Apr. 28, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'FEI CO	'
Entity Central Index Key	'0000914329	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	30-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	42,257,016

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Mar. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current Assets:	'	'
Cash and cash equivalents	$317,666	$384,170
Short-term investments in marketable securities	120,832	108,191
Short-term restricted cash	14,926	18,798
Receivables, net of allowances for doubtful accounts of $3,070 and $2,969	206,906	194,418
Inventories	192,551	181,725
Deferred tax assets	9,884	15,114
Other current assets	30,089	28,324
Total current assets	892,854	930,740
Non-current investments in marketable securities	60,740	47,278
Long-term restricted cash	34,589	32,718
Property, plant and equipment, net of accumulated depreciation of $130,790 and $125,405	163,447	157,829
Intangible assets, net of accumulated amortization of $19,479 and $16,941	67,637	47,197
Goodwill	184,260	136,152
Deferred tax assets	4,261	1,751
Non-current inventories	59,295	62,104
Other assets, net	10,517	10,315
Total Assets	1,477,600	1,426,084
Current Liabilities:	'	'
Accounts payable	94,311	73,247
Accrued payroll liabilities	34,538	45,146
Accrued warranty reserves	13,264	12,705
Short-term deferred revenue	93,098	91,563
Income taxes payable	3,135	4,579
Other current liabilities	52,105	46,374
Total current liabilities	290,451	273,614
Long-term deferred revenue	32,603	30,744
Deferred tax liabilities	11,465	8,931
Other liabilities	36,580	35,227
Commitments and contingencies	'	'
Shareholders’ Equity:	'	'
Preferred stock - 500 shares authorized; none issued and outstanding	0	0
Common stock - 70,000 shares authorized; 42,255 and 42,136 shares issued and outstanding, no par value	646,531	637,482
Retained earnings	412,938	392,958
Accumulated other comprehensive income	47,032	47,128
Total Shareholders’ Equity	1,106,501	1,077,568
Total Liabilities and Shareholders’ Equity	$1,477,600	$1,426,084

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 30, 2014	Dec. 31, 2013
In Thousands, except Per Share data, unless otherwise specified
Assets	'	'
Allowance for doubtful accounts	$3,070	$2,969
Accumulated depreciation	130,790	125,405
Accumulated amortization	$19,479	$16,941
Shareholders’ Equity:	'	'
Preferred stock, shares authorized	500	500
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	70,000	70,000
Common stock, shares issued	42,255	42,136
Common stock, shares outstanding	42,255	42,136
Common stock, no par value	$0	$0

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Net sales:	'	'
Products	$169,298	$169,495
Service	56,966	51,694
Total net sales	226,264	221,189
Cost of sales:	'	'
Products	86,595	85,183
Service	33,345	33,455
Total cost of sales	119,940	118,638
Gross profit	106,324	102,551
Operating expenses:	'	'
Research and development	25,646	24,809
Selling, general and administrative	48,462	43,524
Restructuring, reorganization, relocation and severance	1,331	695
Total operating expenses	75,439	69,028
Operating income	30,885	33,523
Other expense:	'	'
Interest income	152	116
Interest expense	-98	-816
Other, net	-324	-805
Total other expense, net	-270	-1,505
Income before income taxes	30,615	32,018
Income tax expense	5,537	5,217
Net income	$25,078	$26,801
Basic net income per share	$0.59	$0.70
Diluted net income per share	$0.59	$0.65
Cash dividends declared per share	$0.12	$0.08
Shares used in per share calculations:	'	'
Basic	42,191	38,522
Diluted	42,772	42,136

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Net income	$25,078	$26,801
Other comprehensive income, net of taxes:	'	'
Change in cumulative translation adjustment	107	-15,714
Change in unrealized gain on available-for-sale securities	1	7
Change in minimum pension liability	16	-15
Changes due to cash flow hedging instruments:	'	'
Net loss on hedge instruments	-753	-1,925
Reclassification to net income of previously deferred losses related to hedge derivatives instruments	533	322
Comprehensive income	$24,982	$9,476

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net income	$25,078	$26,801
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation	7,066	5,810
Amortization	3,197	2,557
Stock-based compensation	5,139	4,364
Income taxes (receivable) payable, net	-2,898	600
Deferred income taxes	1,455	976
(Increase) decrease, net of acquisitions, in:	'	'
Receivables	-10,760	-9,284
Inventories	-10,930	-1,606
Other assets	4,196	-512
Increase (decrease), net of acquisitions, in:	'	'
Accounts payable	12,542	3,212
Accrued payroll liabilities	-13,725	-9,645
Accrued warranty reserves	545	421
Deferred revenue	1,152	10,587
Accrued restructuring, reorganization, relocation and severance	773	188
Other liabilities	5,619	341
Net cash provided by operating activities	28,449	34,810
Cash flows from investing activities:	'	'
Decrease (increase) in restricted cash	1,907	-3,462
Acquisition of property, plant and equipment	-4,336	-5,043
Payments for acquisitions, net of cash acquired	-64,615	0
Purchase of investments in marketable securities	-75,100	-50,715
Redemption of investments in marketable securities	49,374	34,030
Other	-268	-293
Net cash used in investing activities	-93,038	-25,483
Cash flows from financing activities:	'	'
Dividends paid on common stock	-5,058	-3,078
Withholding taxes paid on issuance of vested restricted stock units	-955	-363
Proceeds from exercise of stock options and employee stock purchases	5,504	4,146
Excess tax benefit for share based payment arrangements	1,866	586
Net cash provided by financing activities	1,357	1,291
Effect of exchange rate changes	-3,272	-5,245
(Decrease) increase in cash and cash equivalents	-66,504	5,373
Cash and cash equivalents:	'	'
Beginning of period	384,170	266,302
End of period	317,666	271,675
Supplemental Cash Flow Information:	'	'
Cash paid for income taxes, net	3,711	2,656
Cash paid for interest	63	56
(Decrease) increase in fixed assets related to transfers with inventories	-240	1,664
Dividends declared but not paid	5,056	3,078
Accrued purchases of plant and equipment	$8,345	$398

Organization_and_Basis_of_Pres

Organization and Basis of Presentation	3 Months Ended
	Mar. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization and Basis of Presentation	'
	ORGANIZATION AND BASIS OF PRESENTATION
	Nature of Business
	We are a leading supplier of scientific instruments and related services for nanoscale applications and solutions for industry and science. We report our revenue based on a group structure organization, which we categorize as the Industry Group and the Science Group.
	Our products include transmission electron microscopes ("TEMs"); scanning electron microscopes ("SEMs"); DualBeamTM systems which combine a SEM and a focused ion beam system ("FIB") on a single platform; stand-alone FIBs; high-performance optical microscopes, three-dimensional modeling software, and service and components to support the products. TEMs provide the highest resolution images of samples and their internal structure, down to the atomic level. SEMs provide detailed images of the surface and shape of samples. Optical microscopes provide a wider field of view than SEMs and TEMs. DualBeams and FIBs image, manipulate, mill and deposit material for a variety of purposes, including preparation of samples for TEMs. Substantially all of these product categories are sold into all of our markets. Individual models of our products are increasingly designed to provide specific solutions and applications in each of our markets.
	Our DualBeam systems include models that have wafer handling capability and are purchased by semiconductor equipment manufacturers (“wafer-level DualBeam systems”) and models that have small stages and are sold to customers in several markets (“small-stage DualBeam systems”).
	Our significant research and development and manufacturing operations are located in Hillsboro, Oregon; Eindhoven, The Netherlands; and Brno, Czech Republic; and our software development is managed principally from Bordeaux, France. Our sales and service operations are conducted in the United States (U.S.) and approximately 50 other countries around the world. We also sell our products through independent agents, distributors and representatives in additional countries.
	Basis of Presentation
	The consolidated financial statements include the accounts of FEI Company and our wholly-owned subsidiaries (collectively, “FEI”). All significant intercompany balances and transactions have been eliminated in consolidation.
	The accompanying consolidated financial statements and condensed footnotes have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments considered necessary for fair presentation have been included. The results of operations for the thirteen week period ended March 30, 2014 are not necessarily indicative of the results to be expected for the full year. For further information, refer to the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2013, which was filed with the Securities and Exchange Commission (“SEC”) on February 21, 2014.
	Use of Estimates in Financial Reporting
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.
	Significant accounting policies and estimates underlying the accompanying consolidated financial statements include:
	•	the timing of revenue recognition;
	•	the allowance for doubtful accounts;
	•	valuations of excess and obsolete inventory;
	•	the lives and recoverability of equipment and other long-lived assets such as goodwill;
	•	the valuations of intangible assets;
	•	restructuring, reorganization, relocation and severance costs;
	•	tax valuation allowances and unrecognized tax benefits;
	•	warranty liabilities;
	•	stock-based compensation; and
	•	accounting for derivatives.
	It is reasonably possible that management's estimates may change in the future.

Earnings_Per_Share

Earnings Per Share	3 Months Ended
	Mar. 30, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share	'
	EARNINGS PER SHARE
	Following is a reconciliation of basic earnings per share (“EPS”) and diluted EPS (in thousands, except per share amounts):
		Thirteen Weeks Ended						Thirteen Weeks Ended
		March 30, 2014						March 31, 2013
		Net			Shares	Per Share		Net		Shares	Per Share
		Income				Amount		Income			Amount
	Basic EPS	$	25,078		42,191	$	0.59	$	26,801	38,522	$	0.7
	Dilutive effect of 2.875% convertible debt	—			—	—		455		3,033	(0.04		)
	Dilutive effect of stock options, restricted stock units, and shares issuable to Philips	—			581	—		—		581	(0.01		)
	Diluted EPS	$	25,078		42,772	$	0.59	$	27,256	42,136	$	0.65
	The following table sets forth the schedule of anti-dilutive securities excluded from the computation of diluted EPS (number of shares, in thousands):
		Thirteen Weeks Ended
		March 30,		March 31,
		2014		2013
	Stock options	138		222
	Restricted stock units	1		2

StockBased_Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock-Based Compensation	'
	STOCK-BASED COMPENSATION
	1995 Stock Incentive Plan
	Our 1995 Stock Incentive Plan, as amended (the “1995 Plan”), allows for the issuance of a maximum of 11,000,000 shares of our common stock.
	The following table sets forth certain information regarding the 1995 Plan:
		March 30,
		2014
	Shares available for grant	2,001,765
	Shares of common stock reserved for issuance	3,364,680
	The following table sets forth certain information regarding all options outstanding and exercisable:
		March 30, 2014
		Options		Options
		Outstanding		Exercisable
	Number	649,059		151,082
	Weighted average exercise price	$	52.82	$	33.96
	Aggregate intrinsic value	$ 32.5 million		$ 10.4 million
	Weighted average remaining contractual term	5.1 years		3.8 years
	The following table sets forth certain information regarding all RSUs nonvested and expected to vest:
		March 30, 2014
		RSUs Nonvested		RSUs Expected
				to Vest
	Number	713,858		627,724
	Weighted average grant date per share fair value	$	58.39	$	57.53
	Aggregate intrinsic value	$ 73.4 million		$ 64.6 million
	Weighted average remaining term to vest	1.5 years		1.5 years
	As of March 30, 2014, unrecognized stock-based compensation related to outstanding, but unvested stock options and RSUs was $43.5 million, which will be recognized over the weighted average remaining vesting period of 1.9 years.
	Stock-Based Compensation Expense
	Our stock-based compensation expense was included in our Consolidated Statements of Operations as follows (in thousands):
		Thirteen Weeks Ended
		March 30,		March 31,
		2014		2013
	Cost of sales	$	726	$	595
	Research and development	617		531
	Selling, general and administrative	3,796		3,238
	Total stock-based compensation	$	5,139	$	4,364

Credit_Facilities_and_Restrict

Credit Facilities and Restricted Cash	3 Months Ended
	Mar. 30, 2014
Credit Facilities And Restricted Cash	'
Credit Facilities and Restricted Cash	'
	CREDIT FACILITIES AND RESTRICTED CASH
	Multibank Credit Agreement
	We have a multibank credit agreement (the “Credit Agreement”), which provides for a $100.0 million secured revolving credit facility, including a $50.0 million subfacility for the issuance of letters of credit. The credit agreement expires in April 2016. We may, upon notice to JPMorgan Chase Bank, N.A., request to increase the revolving loan commitments by an aggregate amount of up to $50.0 million with new or additional commitments subject only to the consent of the lender(s) providing the new or additional commitments, for a total secured credit facility of up to $150.0 million. As of March 30, 2014, there were no revolving loans or letters of credit outstanding under the Credit Agreement, we were in compliance with all covenants and we were not in default under the Credit Agreement.
	Restricted Cash
	As part of our contracts with certain customers, we are required to provide letters of credit or bank guarantees which these customers can draw against in the event we do not perform in accordance with our contractual obligations. Restricted cash balances securing bank guarantees that expire within 12 months of the balance sheet date are recorded as a current asset on our consolidated balance sheets. Restricted cash balances securing bank guarantees that expire beyond 12 months from the balance sheet date are recorded as long-term restricted cash on our consolidated balance sheets.
	The following table sets forth information related to guarantees and letters of credit (in thousands):
		March 30,
		2014
	Guarantees and letters of credit outstanding	$	49,588
	Amount secured by restricted cash deposits:
	Current	$	14,926
	Long-term	34,589
	Total secured by restricted cash	$	49,515

Inventories

Inventories	3 Months Ended
	Mar. 30, 2014
Inventory Disclosure [Abstract]	'
Inventories	'
	INVENTORIES
	Inventories are stated at the lower of cost or market, with cost determined by standard cost methods, which approximate the first-in, first-out method. Inventory costs include material, labor and manufacturing overhead. Service inventories that exceed the estimated requirements for the next 12 months based on recent usage levels are reported as a long-term asset. Management has established inventory reserves based on estimates of excess and/or obsolete current and non-current inventory.
	Inventories consisted of the following (in thousands):
		March 30,		December 31,
		2014		2013
	Raw materials and assembled parts	$	62,191	$	61,235
	Service inventories, estimated current requirements	14,516		15,197
	Work-in-process	84,187		75,883
	Finished goods	31,657		29,410
	Total current inventories	$	192,551	$	181,725
	Non-current inventories	$	59,295	$	62,104

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Other Intangible Assets	'
	GOODWILL AND OTHER INTANGIBLE ASSETS
	Goodwill
	The roll-forward of activity related to our goodwill was as follows (in thousands):
		Thirteen Weeks Ended
		March 30,			March 31,
		2014			2013
	Balance, beginning of period	$	136,152		$	131,320
	Goodwill additions	46,446			—
	Goodwill adjustments	1,662			(3,148		)
	Balance, end of period	$	184,260		$	128,172
	Additions to goodwill represent goodwill from acquisitions made during the period. Adjustments to goodwill include translation adjustments resulting from a portion of our goodwill being recorded on the books of our foreign subsidiaries as well as an adjustment recorded in the first quarter of 2013 related to the finalization of the purchase price allocation of the acquisition of ASPEX Corporation in 2012.
	Acquisition of Lithicon AS
	On February 5, 2014 we acquired 100% of the outstanding shares of Lithicon AS of Trondheim, Norway. Lithicon AS owns 100% of the shares of Lithicon Norway of Trondheim, Norway and Lithicon Australia of Canberra, Australia (collectively "Lithicon.") Lithicon provides digital rock technology services and pore-scale micro computed tomography (microCT) equipment to oil and gas companies. In conjunction with the acquisition we have obtained the helical scan microCT product and associated software from the Australian National University through a licensing and development agreement.
	The total purchase price of the acquisition was $68.0 million, plus an adjustment for the change in final closing accounts. The closing account adjustment is still in the process of final determination. We paid $0.4 million in transaction costs of which $0.3 million was paid in the current quarter. Those costs were expensed as incurred and are recorded in the Selling, general and administrative line on the Consolidated Statements of Operations. The total purchase price was allocated to the net tangible and intangible assets acquired based on their preliminary fair values as of February 5, 2014. The fair value of net tangible assets acquired was $7.7 million and the fair value of net intangible assets acquired was $22.0 million, which consisted of $18.6 million in developed technology, $2.2 million of customer relationships and $1.2 million of purchased backlog. Including an increase to net deferred tax liabilities of $8.1 million, the excess of the purchase price over the fair value of the net assets acquired was $46.4 million, which was recorded as goodwill in the Industry Group. For the thirteen week period ended March 30, 2014 the acquired business added $0.8 million of revenue and a net loss of $1.0 million to our consolidated financial results.
	The goodwill arising from the acquisition of Lithicon is primarily related to expected future cash flows from expansion of our product offerings in the oil and gas market to include digital rock services, as well as synergies from the introduction of the microCT product to the existing FEI product suite.
	The acquired developed technology, customer relationships and purchased backlog will be amortized over a period of 10 years, 5 years and 2 years, respectively.
	No pro forma financial information has been provided for this acquisition as it is insignificant.
	Other Intangible Assets
	Patents, trademarks and other are amortized under the straight-line method over their estimated useful lives of 2 to 10 years. Customer relationships are amortized under the straight-line method over their estimated useful lives of 5 to 10 years. Developed technology is amortized under the straight-line method over the estimated useful life of the related technology, which ranges from 5.5 to 10 years. Note issuance costs were amortized over the life of the related debt, which was 7 years.
	The gross amount of our other intangible assets and the related accumulated amortization were as follows (in thousands):
		March 30,			December 31,
		2014			2013
	Patents, trademarks and other	$	25,827		$	24,327
	Accumulated amortization	(10,283		)	(9,296		)
	Net patents, trademarks and other	15,544			15,031
	Customer relationships	23,852			21,650
	Accumulated amortization	(4,211		)	(3,547		)
	Net customer relationships	19,641			18,103
	Developed technology	37,437			18,161
	Accumulated amortization	(4,985		)	(4,098		)
	Net developed technology	32,452			14,063
	Total intangible assets included in other long-term assets	$	67,637		$	47,197
	Amortization expense was as follows (in thousands):
		Thirteen Weeks Ended
		March 30,			March 31,
		2014			2013
	Patents, trademarks and other	$	1,001		$	919
	Customer relationships	666			505
	Developed technology	887			524
	Note issuance costs	—			87
	Total amortization expense	$	2,554		$	2,035
	Expected amortization, without consideration for foreign currency effects, is as follows over the next five years and thereafter (in thousands):
		Patents,			Customer Relationships			Developed Technology		Total
		Trademarks
		and Other
	Remainder of 2014	$	2,885		$	2,153		$	3,164	$	8,202
	2015	3,695			2,871			4,218		10,784
	2016	2,839			2,871			4,218		9,928
	2017	2,265			2,523			3,938		8,726
	2018	1,649			2,437			3,774		7,860
	Thereafter	2,211			6,786			13,140		22,137
	Total future amortization expense	$	15,544		$	19,641		$	32,452	$	67,637

Warranty_Reserves

Warranty Reserves	3 Months Ended
	Mar. 30, 2014
Product Warranties Disclosures [Abstract]	'
Warranty Reserves	'
	WARRANTY RESERVES
	Our products generally carry a one-year warranty. A reserve is established at the time of sale to cover estimated warranty costs and certain commitments for product upgrades as a component of cost of sales on our consolidated statements of operations. Our estimate of warranty cost is primarily based on our history of warranty repairs and maintenance, as applied to systems currently under warranty. For our new products without a history of known warranty costs, we estimate the expected costs based on our experience with similar product lines and technology. While most new products are extensions of existing technology, the estimate could change if new products require a significantly different level of repair and maintenance than similar products have required in the past. Our estimated warranty costs are reviewed and updated on a quarterly basis. Changes to the reserve occur as volume, product mix and warranty costs fluctuate.
	The following is a summary of warranty reserve activity (in thousands):
		Thirteen Weeks Ended
		March 30,			March 31,
		2014			2013
	Balance, beginning of period	$	12,705		$	12,049
	Reductions for warranty costs incurred	(2,779		)	(3,403		)
	Warranties issued	3,333			3,788
	Translation and changes in estimates	5			(154		)
	Balance, end of period	$	13,264		$	12,280

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	INCOME TAXES
	Our effective income tax rates for the thirteen week periods ended March 30, 2014 and March 31, 2013 were 18.1% and 16.3%, respectively, and reflected taxes accrued in the U.S. and foreign jurisdictions. The tax rate is lower in the comparable period due to U.S. research and experimentation tax credits generated in 2012 and recognized in conjunction with the extension of legislation enacted in January 2013. This legislation expired at the end of 2013, and we have not recognized any benefit related to U.S. research and experimentation credits in the thirteen week period ended March 30, 2014.
	We continue to record a valuation allowance against a portion of our U.S. and foreign deferred tax assets as we do not believe it is more likely than not that we will be able to utilize the deferred tax assets in future periods.
	Deferred Income Taxes
	Net deferred tax assets were classified on the balance sheet as follows (in thousands):
		March 30,			December 31,
		2014			2013
	Deferred tax assets – current	$	9,884		$	15,114
	Deferred tax assets – non-current	4,261			1,751
	Other current liabilities	(53		)	(9		)
	Deferred tax liabilities – non-current	(11,465		)	(8,931		)
	Net deferred tax assets	$	2,627		$	7,925
	Valuation allowance	$	4,514		$	2,723
	Unrecognized Tax Benefits
	During the thirteen week periods ended March 30, 2014 and March 31, 2013, unrecognized tax benefits increased $0.1 million and $0.4 million, respectively, primarily due to uncertainty surrounding permanent establishment and tax credits. The increase for the period ended March 30, 2014 was partially offset by effective settlement of $0.2 million of positions taken on returns in a foreign jurisdiction. There were no increases or decreases in prior unrecognized tax benefits resulting from lapses of statutes of limitations during the period. We recognize interest and penalties related to unrecognized tax benefits in tax expense.
	For our major tax jurisdictions, the following years were open for examination by the tax authorities as of March 30, 2014:
	Jurisdiction		Open Tax Years
	U.S.		2010 and forward
	The Netherlands		2011 and forward
	Czech Republic		2011 and forward

RelatedParty_Activity

Related-Party Activity	3 Months Ended
	Mar. 30, 2014
Related Party Transactions [Abstract]	'
Related-Party Activity	'
	RELATED-PARTY ACTIVITY
	Related parties with which we had transactions during the thirteen week period ended March 30, 2014 were as follows:
	•	one of the members of our Board of Directors serves on the Board of Directors of Applied Materials, Inc. and Lattice Semiconductor Corporation;
	•	our Chief Financial Officer is on the Board of Directors of Cascade Microtech, Inc.;
	•	one of the members of our Board of Directors serves on the Supervisory Board of TMC BV; and
	•	our Chief Executive Officer is on the Board of Trustees for the Oregon Health and Science University Foundation.
	Transactions with these related parties were as follows (in thousands):
		Thirteen Weeks Ended
	Sales to Related Parties	March 30,			March 31,
		2014			2013
	Product sales:
	Applied Materials, Inc.	$	959		$	3,492
	Oregon Health & Science University	130			129
	Total product sales to related parties	1,089			3,621
	Service sales:
	Applied Materials, Inc.	168			133
	Lattice Semiconductor Corporation	3			3
	Cascade Microtech, Inc.	8			8
	Oregon Health & Science University	82			9
	Total service sales to related parties	261			153
	Total sales to related parties	$	1,350		$	3,774
	Purchases from Related Parties
	TMC BV	$	408		$	25
	Oregon Health & Science University	39			—
	Total purchases from related parties	$	447		$	25
	Amounts due from (to) related parties were as follows (in thousands):
		March 30,
		2014
	Applied Materials, Inc.	$	990
	Cascade Microtech, Inc.	8
	Oregon Health & Science University	(28		)
	TMC BV	(290		)
	Due from related parties, net	$	680

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	COMMITMENTS AND CONTINGENCIES
	From time to time, we may be a party to litigation arising in the ordinary course of business. Currently, we are not a party to any litigation that we believe would have a material adverse effect on our financial position, results of operations or cash flows.
	Purchase Obligations
	We have commitments under non-cancelable purchase orders, primarily relating to inventory, totaling 107.9 million at March 30, 2014. These commitments expire at various times through the second quarter of 2016.

Segment_Information

Segment Information	3 Months Ended
	Mar. 30, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	SEGMENT INFORMATION
	Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker is our Chief Executive Officer.
	We currently report our segments based on a group structure organization. Our segments are the Industry Group and the Science Group.
	The following tables summarize various financial amounts for each of our business segments (in thousands):
		Thirteen Weeks Ended
		March 30,		March 31,
		2014		2013
	Sales to External Customers:
	Industry Group	$	106,437	$	99,064
	Science Group	119,827		122,125
	Total	$	226,264	$	221,189
	Gross Profit:
	Industry Group	$	56,132	$	50,514
	Science Group	50,192		52,037
	Total	$	106,324	$	102,551
		March 30,		December 31,
		2014		2013
	Goodwill:
	Industry Group	$	99,688	$	51,532
	Science Group	84,572		84,620
	Total	$	184,260	$	136,152
	Total Assets:
	Industry Group	$	401,073	$	297,987
	Science Group	361,215		365,571
	Corporate and Eliminations	715,312		762,526
	Total	$	1,477,600	$	1,426,084
	Market segment disclosures are presented to the gross profit level as this is the primary performance measure for which the segment general managers are responsible. Selling, general and administrative, research and development and other operating expenses are managed and reported at the corporate level and, given allocation to the market segments would be arbitrary, have not been allocated to the market segments. See the Consolidated Statements of Operations for reconciliations from gross profit to income before income taxes. These reconciling items are not included in the measure of profit and loss for each reportable segment.

Restructuring_Reorganization_R

Restructuring, Reorganization, Relocation and Severance	3 Months Ended
	Mar. 30, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring, Reorganization, Relocation and Severance	'
	RESTRUCTURING, REORGANIZATION, RELOCATION AND SEVERANCE
	First Quarter 2014 Restructuring
	During the first quarter of 2014 we engaged in a restructuring plan principally aimed at consolidating our sales force in Europe. The restructuring plan costs of $1.3 million primarily consisted of severance and related employee termination costs and was completed during the quarter. No future costs under this plan are expected. Savings from this plan is expected to be approximately $1.8 million on an annual basis.
	Group Structure Reorganization
	In January 2013, we announced our intention to reorganize the company into a group structure in order to enable us to efficiently execute our growth strategy. The reorganization was completed in the first quarter of 2013. The costs associated with the reorganization included primarily severance costs and resulted in the termination of certain positions throughout the company. In anticipation of this reorganization, we incurred $2.9 million of costs during the fourth quarter of 2012, and recorded $1.1 million of costs during the first half of 2013, for a total cost of $4.0 million. We expect to incur no additional charges related to the reorganization.
	Restructuring, Reorganization, Relocation and Severance Accrual
	The following table summarizes the charges, expenditures, write-offs and adjustments related to our restructuring, reorganization, relocation and severance accrual (in thousands):
	Thirteen Weeks Ended March 30, 2014	First Quarter 2014 Restructuring			Group Structure Organization			Total
	Beginning accrued liability	$	—		$	50		$	50
	Charged to expense, net	1,331			—			1,331
	Expenditures	(484		)	—			(484		)
	Ending accrued liability	$	847		$	50		$	897
	Thirteen Weeks Ended March 31, 2013	Group Structure Organization			Total
	Beginning accrued liability	$	2,692		$	2,692
	Charged to expense, net	695			695
	Expenditures	(511		)	(511		)
	Write-offs and adjustments	(80		)	(80		)
	Ending accrued liability	$	2,796		$	2,796

Fair_Value_Measurements_of_Ass

Fair Value Measurements of Assets and Liabilities	3 Months Ended
	Mar. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements of Assets and Liabilities	'
	FAIR VALUE MEASUREMENTS OF ASSETS AND LIABILITIES
	Factors used in determining the fair value of our financial assets and liabilities are summarized into three broad categories:
	•	Level 1 – quoted prices in active markets for identical securities as of the reporting date;
	•	Level 2 – other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk; and
	•	Level 3 – significant inputs that are generally less observable than objective sources, including our own assumptions in determining fair value.
	The factors or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
	Following are the disclosures related to the fair value of our financial assets and (liabilities) (in thousands):
	March 30, 2014	Level 1		Level 2			Level 3		Total
	Available for sale marketable securities:
	U.S. Government-backed securities	$	15,092	$	—		$	—	$	15,092
	Agency bonds	—		52,967			—		52,967
	Commercial paper	—		34,989			—		34,989
	Certificates of deposit	—		8,578			—		8,578
	Municipal bonds	—		51,601			—		51,601
	Corporate bonds	—		12,091			—		12,091
	Trading securities:
	Equity securities – mutual funds	6,254		—			—		6,254
	Derivative contracts, net	—		(2,936		)	—		(2,936		)
	Total	$	21,346	$	157,290		$	—	$	178,636
	December 31, 2013	Level 1		Level 2			Level 3		Total
	Available for sale marketable securities:
	U.S. treasury notes	$	10,128	$	—		$	—	$	10,128
	Agency bonds	—		37,961			—		37,961
	Commercial paper	—		39,987			—		39,987
	Certificates of deposit	—		7,786			—		7,786
	Municipal bonds	—		49,319			—		49,319
	Corporate bonds	—		5,001			—		5,001
	Trading securities:
	Equity securities – mutual funds	5,287		—			—		5,287
	Derivative contracts, net	—		(1,113		)	—		(1,113		)
	Total	$	15,415	$	138,941		$	—	$	154,356
	Agency bonds are securities backed by U.S. government-sponsored entities. U.S. Government-backed securities include Treasury Bills and Treasury Notes.
	We use an income approach to value the assets and liabilities for outstanding derivative contracts using current market information as of the reporting date, such as spot rates, interest rate differentials and implied volatility.
	There were no transfers between fair value categories or changes to our valuation techniques during the thirteen week period ended March 30, 2014.
	We believe the carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and other current liabilities are a reasonable approximation of the fair value of those financial instruments because of the nature of the underlying transactions and the short-term maturities involved.

Derivative_Instruments

Derivative Instruments	3 Months Ended
	Mar. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Instruments	'
	DERIVATIVE INSTRUMENTS
	In the normal course of business, we are exposed to foreign currency risk and we use derivatives to mitigate financial exposure from movements in foreign currency exchange rates.
	The aggregate notional amount of outstanding derivative contracts were as follows (in thousands):
		March 30,				December 31,
		2014				2013
	Cash flow hedges	$	177,397			$	208,446
	Balance sheet hedges	158,511				172,947
	Total outstanding derivative contracts	$	335,908			$	381,393
	The outstanding contracts at March 30, 2014 have varying maturities through the third quarter of 2015. We do not enter into derivative financial instruments for speculative purposes.
	We attempt to mitigate derivative credit risk by transacting with highly rated counterparties. We have evaluated the credit and nonperformance risks associated with our derivative counterparties and believe them to be insignificant and not warranting a credit adjustment at March 30, 2014. In addition, there are no credit contingent features in our derivative instruments.
	Balance Sheet Related
	In countries outside of the U.S., we transact business in U.S. dollars and in various other currencies. We attempt to mitigate our currency exposures for recorded transactions by using forward exchange contracts to reduce the risk that our future cash flows will be adversely affected by changes in exchange rates. We enter into forward sale or purchase contracts for foreign currencies to economically hedge specific cash, receivables or payables positions denominated in foreign currencies.
	Changes in fair value of derivatives entered into to mitigate the foreign exchange risks related to these balance sheet items are recorded in other income (expense) together with the transaction gain or loss from the respective balance sheet position as follows (in thousands):
		Thirteen Weeks Ended
		March 30,				March 31,
		2014				2013
	Foreign currency loss, inclusive of the impact of derivatives	$	(230	)		$	(599	)
	Cash Flow Hedges
	We use zero cost collar contracts and option contracts to hedge certain anticipated foreign currency exchange transactions. The foreign exchange hedging structure is set up, generally, on a twenty-four month time horizon. The hedging transactions we undertake primarily limit our exposure to changes in the U.S. dollar/euro and the U.S. dollar/Czech koruna exchange rate. The zero cost collar contract hedges are designed to protect us as the U.S. dollar weakens, but also provide us with some flexibility if the dollar strengthens.
	These derivatives meet the criteria to be designated as hedges and, accordingly, we record the change in fair value of the effective portion of these hedge contracts relating to anticipated transactions in other comprehensive income rather than net income until the underlying hedged transaction affects net income. Gains and losses resulting from the ineffective portion of the hedge contracts, if any, are recognized as a component of net income. Gains and losses related to cash flow derivative contracts not designated as hedging instruments are recorded as a component of net income.
	Summary
	Our derivative instruments are subject to master netting arrangements and are presented net in our balance sheet. We do not have any financial collateral related to these netting arrangements. The effect of these netting arrangements on our balance sheet is as follows (in thousands):
		Offsetting of Derivative Assets								Offsetting of Derivative Liabilities
	March 30, 2014	Gross Amounts of Recognized Assets			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Assets		Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Liabilities
	Foreign exchange contracts designated as hedging instruments	$	—		$	—		$	—	$	3,876	$	(2,065	)	$	1,811
	Foreign exchange contracts not designated as hedging instruments	720			(275		)	445		2,203		(633		)	1,570
	Total	$	720		$	(275	)	$	445	$	6,079	$	(2,698	)	$	3,381
		Offsetting of Derivative Assets								Offsetting of Derivative Liabilities
	December 31, 2013	Gross Amounts of Recognized Assets			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Assets		Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Liabilities
	Foreign exchange contracts designated as hedging instruments	$	—		$	—		$	—	$	4,362	$	(3,042	)	$	1,320
	Foreign exchange contracts not designated as hedging instruments	2,171			(698		)	1,473		2,916		(1,650		)	1,266
	Total	$	2,171		$	(698	)	$	1,473	$	7,278	$	(4,692	)	$	2,586
	The effect of derivative instruments was as follows (in thousands):
		Thirteen Weeks Ended
	Foreign Exchange Contracts in Cash Flow Hedging Relationships	March 30,				March 31,
		2014				2013
	Amount of gain/(loss):
	Recognized in OCI (effective portion)	$	(2,202	)		$	(1,799	)
	Reclassified from accumulated OCI into revenue (effective portion)	37				—
	Reclassified from accumulated OCI into cost of sales (effective portion)	(570		)		(297		)
	Recognized in other, net (ineffective portion and amount excluded from effectiveness testing)	—				(25		)
	Foreign Exchange Contracts Not in Cash Flow Hedging Relationships
	Amount of gain/(loss):
	Recognized in other, net	$	3,109			$	767
	The unrealized losses at March 30, 2014 are expected to be reclassified to net income during the next eighteen months as a result of the underlying hedged transactions also being recorded in net income.

Changes_in_Accumulated_Other_C

Changes in Accumulated Other Comprehensive Income by Component (Notes)	3 Months Ended
	Mar. 30, 2014
Changes in Accumulated Other Comprehensive Income [Abstract]	'
Comprehensive Income Note [Text Block]	'
	CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT
	The following tables illustrate the disclosure of changes in the balances of each component of accumulated other comprehensive income ("AOCI"), as well as details the effect of reclassifications out of AOCI on the line items in the Consolidated Statements of Operations by component (net of tax, in thousands):
		Thirteen Weeks Ended March 30, 2014
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	48,865		$	(11	)	$	(552	)	$	(1,174	)	$	47,128
	Other comprehensive income before reclassifications	107			1			16			(753		)	(629		)
	Amounts reclassified from AOCI to:
	Revenue	—			—			—			(37		)	(37		)
	Cost of goods sold	—			—			—			570			570
	Other income (expense)	—			—			—			—			—
	Total reclassifications out of AOCI	—			—			—			533			533
	Net current period other comprehensive income	107			1			16			(220		)	(96		)
	Ending balance	$	48,972		$	(10	)	$	(536	)	$	(1,394	)	$	47,032
		Thirteen Weeks Ended March 31, 2013
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	38,890		$	4		$	(819	)	$	481		$	38,556
	Other comprehensive income before reclassifications	(15,714		)	7			(15		)	(1,925		)	(17,647		)
	Amounts reclassified from AOCI to:
	Cost of goods sold	—			—			—			297			297
	Other income (expense)	—			—			—			25			25
	Total reclassifications out of AOCI	—			—			—			322			322
	Net current period other comprehensive income	(15,714		)	7			(15		)	(1,603		)	(17,325		)
	Ending balance	$	23,176		$	11		$	(834	)	$	(1,122	)	$	21,231

New_Accounting_Pronouncements

New Accounting Pronouncements	3 Months Ended
	Mar. 30, 2014
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]	'
New Accounting Pronouncements	'
	NEW ACCOUNTING PRONOUNCEMENTS
	Recent accounting pronouncements issued by the Financial Accounting Standards Board and the United States Exchange Commission did not have a material impact on the Company's financial statements.

Organization_and_Basis_of_Pres1

Organization and Basis of Presentation (Policies)	3 Months Ended
	Mar. 30, 2014
Accounting Policies [Abstract]	'
Consolidation Policy	'
	The consolidated financial statements include the accounts of FEI Company and our wholly-owned subsidiaries (collectively, “FEI”). All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates Policy	'
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.
Restricted Cash Policy	'
	As part of our contracts with certain customers, we are required to provide letters of credit or bank guarantees which these customers can draw against in the event we do not perform in accordance with our contractual obligations. Restricted cash balances securing bank guarantees that expire within 12 months of the balance sheet date are recorded as a current asset on our consolidated balance sheets. Restricted cash balances securing bank guarantees that expire beyond 12 months from the balance sheet date are recorded as long-term restricted cash on our consolidated balance sheets.
Inventories Policy	'
	Inventories are stated at the lower of cost or market, with cost determined by standard cost methods, which approximate the first-in, first-out method. Inventory costs include material, labor and manufacturing overhead. Service inventories that exceed the estimated requirements for the next 12 months based on recent usage levels are reported as a long-term asset. Management has established inventory reserves based on estimates of excess and/or obsolete current and non-current inventory.
Intangible Assets Policy	'
	Patents, trademarks and other are amortized under the straight-line method over their estimated useful lives of 2 to 10 years. Customer relationships are amortized under the straight-line method over their estimated useful lives of 5 to 10 years. Developed technology is amortized under the straight-line method over the estimated useful life of the related technology, which ranges from 5.5 to 10 years. Note issuance costs were amortized over the life of the related debt, which was 7 years.
Warranty Liabilities Policy	'
	Our products generally carry a one-year warranty. A reserve is established at the time of sale to cover estimated warranty costs and certain commitments for product upgrades as a component of cost of sales on our consolidated statements of operations. Our estimate of warranty cost is primarily based on our history of warranty repairs and maintenance, as applied to systems currently under warranty. For our new products without a history of known warranty costs, we estimate the expected costs based on our experience with similar product lines and technology. While most new products are extensions of existing technology, the estimate could change if new products require a significantly different level of repair and maintenance than similar products have required in the past. Our estimated warranty costs are reviewed and updated on a quarterly basis. Changes to the reserve occur as volume, product mix and warranty costs fluctuate.

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	3 Months Ended
	Mar. 30, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share Reconciliation	'
	Following is a reconciliation of basic earnings per share (“EPS”) and diluted EPS (in thousands, except per share amounts):
		Thirteen Weeks Ended						Thirteen Weeks Ended
		March 30, 2014						March 31, 2013
		Net			Shares	Per Share		Net		Shares	Per Share
		Income				Amount		Income			Amount
	Basic EPS	$	25,078		42,191	$	0.59	$	26,801	38,522	$	0.7
	Dilutive effect of 2.875% convertible debt	—			—	—		455		3,033	(0.04		)
	Dilutive effect of stock options, restricted stock units, and shares issuable to Philips	—			581	—		—		581	(0.01		)
	Diluted EPS	$	25,078		42,772	$	0.59	$	27,256	42,136	$	0.65
Schedule of Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share	'
	The following table sets forth the schedule of anti-dilutive securities excluded from the computation of diluted EPS (number of shares, in thousands):
		Thirteen Weeks Ended
		March 30,		March 31,
		2014		2013
	Stock options	138		222
	Restricted stock units	1		2

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Information Related to Stock-Based Compensation Plans	'
	The following table sets forth certain information regarding the 1995 Plan:
		March 30,
		2014
	Shares available for grant	2,001,765
	Shares of common stock reserved for issuance	3,364,680
Schedule of Options Outstanding and Exercisable	'
	The following table sets forth certain information regarding all options outstanding and exercisable:
		March 30, 2014
		Options		Options
		Outstanding		Exercisable
	Number	649,059		151,082
	Weighted average exercise price	$	52.82	$	33.96
	Aggregate intrinsic value	$ 32.5 million		$ 10.4 million
	Weighted average remaining contractual term	5.1 years		3.8 years
Schedule of Restricted Stock Units Nonvested and Expected to Vest	'
	The following table sets forth certain information regarding all RSUs nonvested and expected to vest:
		March 30, 2014
		RSUs Nonvested		RSUs Expected
				to Vest
	Number	713,858		627,724
	Weighted average grant date per share fair value	$	58.39	$	57.53
	Aggregate intrinsic value	$ 73.4 million		$ 64.6 million
	Weighted average remaining term to vest	1.5 years		1.5 years
Schedule of Stock-Based Compensation Expense	'
	Our stock-based compensation expense was included in our Consolidated Statements of Operations as follows (in thousands):
		Thirteen Weeks Ended
		March 30,		March 31,
		2014		2013
	Cost of sales	$	726	$	595
	Research and development	617		531
	Selling, general and administrative	3,796		3,238
	Total stock-based compensation	$	5,139	$	4,364

Credit_Facilities_and_Restrict1

Credit Facilities and Restricted Cash (Tables)	3 Months Ended
	Mar. 30, 2014
Credit Facilities And Restricted Cash	'
Schedule of Letters of Credit and Restricted Cash	'
	The following table sets forth information related to guarantees and letters of credit (in thousands):
		March 30,
		2014
	Guarantees and letters of credit outstanding	$	49,588
	Amount secured by restricted cash deposits:
	Current	$	14,926
	Long-term	34,589
	Total secured by restricted cash	$	49,515

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Mar. 30, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventories	'
	Inventories consisted of the following (in thousands):
		March 30,		December 31,
		2014		2013
	Raw materials and assembled parts	$	62,191	$	61,235
	Service inventories, estimated current requirements	14,516		15,197
	Work-in-process	84,187		75,883
	Finished goods	31,657		29,410
	Total current inventories	$	192,551	$	181,725
	Non-current inventories	$	59,295	$	62,104

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Mar. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill Activity	'
	The roll-forward of activity related to our goodwill was as follows (in thousands):
		Thirteen Weeks Ended
		March 30,			March 31,
		2014			2013
	Balance, beginning of period	$	136,152		$	131,320
	Goodwill additions	46,446			—
	Goodwill adjustments	1,662			(3,148		)
	Balance, end of period	$	184,260		$	128,172
Schedule of Finite-Lived Intangible Assets by Major Class	'
	The gross amount of our other intangible assets and the related accumulated amortization were as follows (in thousands):
		March 30,			December 31,
		2014			2013
	Patents, trademarks and other	$	25,827		$	24,327
	Accumulated amortization	(10,283		)	(9,296		)
	Net patents, trademarks and other	15,544			15,031
	Customer relationships	23,852			21,650
	Accumulated amortization	(4,211		)	(3,547		)
	Net customer relationships	19,641			18,103
	Developed technology	37,437			18,161
	Accumulated amortization	(4,985		)	(4,098		)
	Net developed technology	32,452			14,063
	Total intangible assets included in other long-term assets	$	67,637		$	47,197
Schedule of Amortization Expense by Major Class	'
	Amortization expense was as follows (in thousands):
		Thirteen Weeks Ended
		March 30,			March 31,
		2014			2013
	Patents, trademarks and other	$	1,001		$	919
	Customer relationships	666			505
	Developed technology	887			524
	Note issuance costs	—			87
	Total amortization expense	$	2,554		$	2,035
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	'
	Expected amortization, without consideration for foreign currency effects, is as follows over the next five years and thereafter (in thousands):
		Patents,			Customer Relationships			Developed Technology		Total
		Trademarks
		and Other
	Remainder of 2014	$	2,885		$	2,153		$	3,164	$	8,202
	2015	3,695			2,871			4,218		10,784
	2016	2,839			2,871			4,218		9,928
	2017	2,265			2,523			3,938		8,726
	2018	1,649			2,437			3,774		7,860
	Thereafter	2,211			6,786			13,140		22,137
	Total future amortization expense	$	15,544		$	19,641		$	32,452	$	67,637

Warranty_Reserves_Tables

Warranty Reserves (Tables)	3 Months Ended
	Mar. 30, 2014
Product Warranties Disclosures [Abstract]	'
Schedule of Warranty Reserve Activity	'
	The following is a summary of warranty reserve activity (in thousands):
		Thirteen Weeks Ended
		March 30,			March 31,
		2014			2013
	Balance, beginning of period	$	12,705		$	12,049
	Reductions for warranty costs incurred	(2,779		)	(3,403		)
	Warranties issued	3,333			3,788
	Translation and changes in estimates	5			(154		)
	Balance, end of period	$	13,264		$	12,280

Income_Taxes_Tables

Income Taxes (Tables)	3 Months Ended
	Mar. 30, 2014
Income Tax Disclosure [Abstract]	'
Schedule of Deferred Tax Assets and Liabilities, Balance Sheet Classification	'
	Net deferred tax assets were classified on the balance sheet as follows (in thousands):
		March 30,			December 31,
		2014			2013
	Deferred tax assets – current	$	9,884		$	15,114
	Deferred tax assets – non-current	4,261			1,751
	Other current liabilities	(53		)	(9		)
	Deferred tax liabilities – non-current	(11,465		)	(8,931		)
	Net deferred tax assets	$	2,627		$	7,925
	Valuation allowance	$	4,514		$	2,723
Open Tax Years By Major Tax Jurisdiction	'
	For our major tax jurisdictions, the following years were open for examination by the tax authorities as of March 30, 2014:
	Jurisdiction		Open Tax Years
	U.S.		2010 and forward
	The Netherlands		2011 and forward
	Czech Republic		2011 and forward

RelatedParty_Activity_Tables

Related-Party Activity (Tables)	3 Months Ended
	Mar. 30, 2014
Related Party Transactions [Abstract]	'
Schedule of Transactions with Related Parties	'
	Transactions with these related parties were as follows (in thousands):
		Thirteen Weeks Ended
	Sales to Related Parties	March 30,			March 31,
		2014			2013
	Product sales:
	Applied Materials, Inc.	$	959		$	3,492
	Oregon Health & Science University	130			129
	Total product sales to related parties	1,089			3,621
	Service sales:
	Applied Materials, Inc.	168			133
	Lattice Semiconductor Corporation	3			3
	Cascade Microtech, Inc.	8			8
	Oregon Health & Science University	82			9
	Total service sales to related parties	261			153
	Total sales to related parties	$	1,350		$	3,774
	Purchases from Related Parties
	TMC BV	$	408		$	25
	Oregon Health & Science University	39			—
	Total purchases from related parties	$	447		$	25
Schedule of Amounts Due From (To) Related Parties	'
	Amounts due from (to) related parties were as follows (in thousands):
		March 30,
		2014
	Applied Materials, Inc.	$	990
	Cascade Microtech, Inc.	8
	Oregon Health & Science University	(28		)
	TMC BV	(290		)
	Due from related parties, net	$	680

Segment_Information_Tables

Segment Information (Tables)	3 Months Ended
	Mar. 30, 2014
Segment Reporting [Abstract]	'
Schedule of Sales to External Customers and Gross Profit by Segment	'
	The following tables summarize various financial amounts for each of our business segments (in thousands):
		Thirteen Weeks Ended
		March 30,		March 31,
		2014		2013
	Sales to External Customers:
	Industry Group	$	106,437	$	99,064
	Science Group	119,827		122,125
	Total	$	226,264	$	221,189
	Gross Profit:
	Industry Group	$	56,132	$	50,514
	Science Group	50,192		52,037
	Total	$	106,324	$	102,551
Schedule of Goodwill and Total Assets by Segment	'
		March 30,		December 31,
		2014		2013
	Goodwill:
	Industry Group	$	99,688	$	51,532
	Science Group	84,572		84,620
	Total	$	184,260	$	136,152
	Total Assets:
	Industry Group	$	401,073	$	297,987
	Science Group	361,215		365,571
	Corporate and Eliminations	715,312		762,526
	Total	$	1,477,600	$	1,426,084

Restructuring_Reorganization_R1

Restructuring, Reorganization, Relocation and Severance (Tables)	3 Months Ended
	Mar. 30, 2014
Restructuring and Related Activities [Abstract]	'
Schedule of Restructuring Reserve by Type of Cost	'
	The following table summarizes the charges, expenditures, write-offs and adjustments related to our restructuring, reorganization, relocation and severance accrual (in thousands):
	Thirteen Weeks Ended March 30, 2014	First Quarter 2014 Restructuring			Group Structure Organization			Total
	Beginning accrued liability	$	—		$	50		$	50
	Charged to expense, net	1,331			—			1,331
	Expenditures	(484		)	—			(484		)
	Ending accrued liability	$	847		$	50		$	897
	Thirteen Weeks Ended March 31, 2013	Group Structure Organization			Total
	Beginning accrued liability	$	2,692		$	2,692
	Charged to expense, net	695			695
	Expenditures	(511		)	(511		)
	Write-offs and adjustments	(80		)	(80		)
	Ending accrued liability	$	2,796		$	2,796

Fair_Value_Measurements_of_Ass1

Fair Value Measurements of Assets and Liabilities (Tables)	3 Months Ended
	Mar. 30, 2014
Fair Value Disclosures [Abstract]	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	'
	Following are the disclosures related to the fair value of our financial assets and (liabilities) (in thousands):
	March 30, 2014	Level 1		Level 2			Level 3		Total
	Available for sale marketable securities:
	U.S. Government-backed securities	$	15,092	$	—		$	—	$	15,092
	Agency bonds	—		52,967			—		52,967
	Commercial paper	—		34,989			—		34,989
	Certificates of deposit	—		8,578			—		8,578
	Municipal bonds	—		51,601			—		51,601
	Corporate bonds	—		12,091			—		12,091
	Trading securities:
	Equity securities – mutual funds	6,254		—			—		6,254
	Derivative contracts, net	—		(2,936		)	—		(2,936		)
	Total	$	21,346	$	157,290		$	—	$	178,636
	December 31, 2013	Level 1		Level 2			Level 3		Total
	Available for sale marketable securities:
	U.S. treasury notes	$	10,128	$	—		$	—	$	10,128
	Agency bonds	—		37,961			—		37,961
	Commercial paper	—		39,987			—		39,987
	Certificates of deposit	—		7,786			—		7,786
	Municipal bonds	—		49,319			—		49,319
	Corporate bonds	—		5,001			—		5,001
	Trading securities:
	Equity securities – mutual funds	5,287		—			—		5,287
	Derivative contracts, net	—		(1,113		)	—		(1,113		)
	Total	$	15,415	$	138,941		$	—	$	154,356

Derivative_Instruments_Tables

Derivative Instruments (Tables)	3 Months Ended
	Mar. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Schedule of Notional Amounts of Outstanding Derivative Positions	'
	The aggregate notional amount of outstanding derivative contracts were as follows (in thousands):
		March 30,				December 31,
		2014				2013
	Cash flow hedges	$	177,397			$	208,446
	Balance sheet hedges	158,511				172,947
	Total outstanding derivative contracts	$	335,908			$	381,393
Schedule of Gain (Loss) Attributable to Foreign Exchange Rate Fluctuations	'
	Changes in fair value of derivatives entered into to mitigate the foreign exchange risks related to these balance sheet items are recorded in other income (expense) together with the transaction gain or loss from the respective balance sheet position as follows (in thousands):
		Thirteen Weeks Ended
		March 30,				March 31,
		2014				2013
	Foreign currency loss, inclusive of the impact of derivatives	$	(230	)		$	(599	)
Schedule of Derivatives Instruments, Offsetting in Balance Sheet	'
	Our derivative instruments are subject to master netting arrangements and are presented net in our balance sheet. We do not have any financial collateral related to these netting arrangements. The effect of these netting arrangements on our balance sheet is as follows (in thousands):
		Offsetting of Derivative Assets								Offsetting of Derivative Liabilities
	March 30, 2014	Gross Amounts of Recognized Assets			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Assets		Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Liabilities
	Foreign exchange contracts designated as hedging instruments	$	—		$	—		$	—	$	3,876	$	(2,065	)	$	1,811
	Foreign exchange contracts not designated as hedging instruments	720			(275		)	445		2,203		(633		)	1,570
	Total	$	720		$	(275	)	$	445	$	6,079	$	(2,698	)	$	3,381
		Offsetting of Derivative Assets								Offsetting of Derivative Liabilities
	December 31, 2013	Gross Amounts of Recognized Assets			Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Assets		Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Balance Sheet			Net Amounts Presented in Other Current Liabilities
	Foreign exchange contracts designated as hedging instruments	$	—		$	—		$	—	$	4,362	$	(3,042	)	$	1,320
	Foreign exchange contracts not designated as hedging instruments	2,171			(698		)	1,473		2,916		(1,650		)	1,266
	Total	$	2,171		$	(698	)	$	1,473	$	7,278	$	(4,692	)	$	2,586
Schedule of Derivative Instruments, Gain (Loss) in Statement of Operations	'
	The effect of derivative instruments was as follows (in thousands):
		Thirteen Weeks Ended
	Foreign Exchange Contracts in Cash Flow Hedging Relationships	March 30,				March 31,
		2014				2013
	Amount of gain/(loss):
	Recognized in OCI (effective portion)	$	(2,202	)		$	(1,799	)
	Reclassified from accumulated OCI into revenue (effective portion)	37				—
	Reclassified from accumulated OCI into cost of sales (effective portion)	(570		)		(297		)
	Recognized in other, net (ineffective portion and amount excluded from effectiveness testing)	—				(25		)
	Foreign Exchange Contracts Not in Cash Flow Hedging Relationships
	Amount of gain/(loss):
	Recognized in other, net	$	3,109			$	767

Changes_in_Accumulated_Other_C1

Changes in Accumulated Other Comprehensive Income by Component (Tables)	3 Months Ended
	Mar. 30, 2014
Changes in Accumulated Other Comprehensive Income [Abstract]	'
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	The following tables illustrate the disclosure of changes in the balances of each component of accumulated other comprehensive income ("AOCI"), as well as details the effect of reclassifications out of AOCI on the line items in the Consolidated Statements of Operations by component (net of tax, in thousands):
		Thirteen Weeks Ended March 30, 2014
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	48,865		$	(11	)	$	(552	)	$	(1,174	)	$	47,128
	Other comprehensive income before reclassifications	107			1			16			(753		)	(629		)
	Amounts reclassified from AOCI to:
	Revenue	—			—			—			(37		)	(37		)
	Cost of goods sold	—			—			—			570			570
	Other income (expense)	—			—			—			—			—
	Total reclassifications out of AOCI	—			—			—			533			533
	Net current period other comprehensive income	107			1			16			(220		)	(96		)
	Ending balance	$	48,972		$	(10	)	$	(536	)	$	(1,394	)	$	47,032
		Thirteen Weeks Ended March 31, 2013
		Foreign Currency Items			Unrealized Gains and Losses on Available-for-Sale Securities			Defined Benefit Pension Items			Gains and Losses on Cash Flow Hedges			Total
	Beginning Balance	$	38,890		$	4		$	(819	)	$	481		$	38,556
	Other comprehensive income before reclassifications	(15,714		)	7			(15		)	(1,925		)	(17,647		)
	Amounts reclassified from AOCI to:
	Cost of goods sold	—			—			—			297			297
	Other income (expense)	—			—			—			25			25
	Total reclassifications out of AOCI	—			—			—			322			322
	Net current period other comprehensive income	(15,714		)	7			(15		)	(1,603		)	(17,325		)
	Ending balance	$	23,176		$	11		$	(834	)	$	(1,122	)	$	21,231

Organization_and_Basis_of_Pres2

Organization and Basis of Presentation (Details)	Mar. 30, 2014
	country
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Number of Countries in which Entity Operates	50

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Earnings Per Share Reconciliation	'	'
Basic EPS	$25,078	$26,801
Basic EPS - shares	42,191	38,522
Basic EPS - per share amount	$0.59	$0.70
Dilutive effect of 2.875% convertible debt - net income	0	455
Dilutive effect of 2.875% convertible debt - shares	0	3,033
Dilutive effect of 2.875% convertible debt - per share amount	$0	($0.04)
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips - net income	0	0
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips - shares	581	581
Dilutive effect of stock options, restricted stock units, and shares issuable to Philips - per share amount	$0	($0.01)
Diluted EPS - net income	$25,078	$27,256
Diluted EPS - shares	42,772	42,136
Diluted EPS - per share amount	$0.59	$0.65

Earnings_Per_Share_Antidilutiv

Earnings Per Share - Antidilutive Securities (Details)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Stock options [Member]	'	'
Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share [Line Items]	'	'
Antidilutive securities excluded from computation of diluted EPS	138	222
Restricted Stock Units [Member]	'	'
Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share [Line Items]	'	'
Antidilutive securities excluded from computation of diluted EPS	1	2

Earnings_Per_Share_Additional_

Earnings Per Share - Additional Information (Details) (Convertible Debt [Member])	Mar. 31, 2013
Convertible Debt [Member]	'
Debt Instrument [Line Items]	'
Debt Instrument, Interest Rate, Stated Percentage	2.88%

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares available for grant	2,001,765
Shares of common stock reserved for issuance	3,364,680
Total compensation cost not yet recognized	$43.50
Total compensation cost not yet recognized - period for recognition	'1 year 10 months 24 days
Stock Incentive Plan [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of shares authorized	11,000,000
Stock Options [Member]	'
Options Outstanding and Exercisable:	'
Options outstanding, number	649,059
Options exercisable, number	151,082
Options outstanding, weighted average exercise price	$52.82
Options exercisable, weighted average exercise price	$33.96
Options outstanding, aggregate intrinsic value	32.5
Options exercisable, aggregate intrinsic value	10.4
Options outstanding, weighted average remaining contractual term (in years)	'5 years 1 month 6 days
Options exercisable, weighted average remaining contractual term (in years)	'3 years 9 months 18 days
Restricted Stock Units [Member]	'
Restricted Stock Units Nonvested and Expected to Vest	'
Restricted stock units nonvested, number	713,858
Restricted stock units expected to vest, number	627,724
Restricted stock units nonvested, weighted average grant date per share fair value	$58.39
Restricted stock units expected to vest, weighted average grant date per share fair value	$57.53
Restricted stock units nonvested, aggregate intrinsic value	73.4
Restricted stock units expected to vest, aggregate intrinsic value	$64.60
Restricted stock units nonvested, weighted average remaining term to vest (in years)	'1 year 6 months 1 day
Restricted stock units expected to vest, weighted average remaining term to vest (in years)	'1 year 6 months 1 day

StockBased_Compensation_Alloca

Stock-Based Compensation - Allocation in Income Statement (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation expense	$5,139	$4,364
Cost of Sales [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation expense	726	595
Research and Development Expense [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation expense	617	531
Selling, General and Administrative [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation expense	$3,796	$3,238

Credit_Facilities_and_Restrict2

Credit Facilities and Restricted Cash - Credit Facilities (Details) (USD $)	3 Months Ended
	Mar. 30, 2014
Revolving Credit Facility [Member]	'
Line of Credit Facility [Line Items]	'
Line of credit facility, current borrowing capacity	$100,000,000
Line of credit facility, additional borrowing capacity	50,000,000
Line of credit facility, maximum borrowing capacity	150,000,000
Credit Facility, Subfacility [Member]	'
Line of Credit Facility [Line Items]	'
Line of credit facility, current borrowing capacity	50,000,000
Credit Agreement [Member]	'
Line of Credit Facility [Line Items]	'
Line of credit facility, expiration date	1-Apr-16
Line of credit facility, amount outstanding	$0

Credit_Facilities_and_Restrict3

Credit Facilities and Restricted Cash - Letters of Credit and Restricted Cash (Details) (USD $)	Mar. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
CREDIT FACILITIES AND RESTRICTED CASH [Abstract]	'	'
Guarantees and letters of credit outstanding	$49,588	'
Short-term restricted cash	14,926	18,798
Long-term restricted cash	34,589	32,718
Total secured by restricted cash	$49,515	'

Inventories_Details

Inventories (Details) (USD $)	Mar. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]	'	'
Raw materials and assembled parts	$62,191	$61,235
Service inventories, estimated current requirements	14,516	15,197
Work-in-process	84,187	75,883
Finished goods	31,657	29,410
Total current inventories	192,551	181,725
Non-current inventories	$59,295	$62,104

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets - Goodwill (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Goodwill [Roll Forward]	'	'
Goodwill, beginning of period	$136,152	$131,320
Goodwill additions	46,446	0
Goodwill adjustments	1,662	-3,148
Goodwill, end of period	$184,260	$128,172

Goodwill_and_Other_Intangible_3

Goodwill and Other Intangible Assets - Intangible Assets (Details) (USD $)	Mar. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-lived intangible assets, accumulated amortization	($19,479)	($16,941)
Finite-lived intangible assets, net	67,637	47,197
Patents trademarks and other [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-lived intangible assets, gross	25,827	24,327
Finite-lived intangible assets, accumulated amortization	-10,283	-9,296
Finite-lived intangible assets, net	15,544	15,031
Customer relationships [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-lived intangible assets, gross	23,852	21,650
Finite-lived intangible assets, accumulated amortization	-4,211	-3,547
Finite-lived intangible assets, net	19,641	18,103
Developed technology [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Finite-lived intangible assets, gross	37,437	18,161
Finite-lived intangible assets, accumulated amortization	-4,985	-4,098
Finite-lived intangible assets, net	$32,452	$14,063

Goodwill_and_Other_Intangible_4

Goodwill and Other Intangible Assets - Amortization of Intangibles (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013	Dec. 31, 2013
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, amortization expense	$2,554	$2,035	'
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'	'
Expected amortization, remainder of 2014	8,202	'	'
Expected amortization, 2015	10,784	'	'
Expected amortization, 2016	9,928	'	'
Expected amortization, 2017	8,726	'	'
Expected amortization, 2018	7,860	'	'
Expected amortization thereafter	22,137	'	'
Total expected amortization expense	67,637	'	47,197
Patents trademarks and other [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, amortization expense	1,001	919	'
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'	'
Expected amortization, remainder of 2014	2,885	'	'
Expected amortization, 2015	3,695	'	'
Expected amortization, 2016	2,839	'	'
Expected amortization, 2017	2,265	'	'
Expected amortization, 2018	1,649	'	'
Expected amortization thereafter	2,211	'	'
Total expected amortization expense	15,544	'	15,031
Customer relationships [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, amortization expense	666	505	'
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'	'
Expected amortization, remainder of 2014	2,153	'	'
Expected amortization, 2015	2,871	'	'
Expected amortization, 2016	2,871	'	'
Expected amortization, 2017	2,523	'	'
Expected amortization, 2018	2,437	'	'
Expected amortization thereafter	6,786	'	'
Total expected amortization expense	19,641	'	18,103
Developed technology [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, amortization expense	887	524	'
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]	'	'	'
Expected amortization, remainder of 2014	3,164	'	'
Expected amortization, 2015	4,218	'	'
Expected amortization, 2016	4,218	'	'
Expected amortization, 2017	3,938	'	'
Expected amortization, 2018	3,774	'	'
Expected amortization thereafter	13,140	'	'
Total expected amortization expense	32,452	'	14,063
Note issuance costs [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, amortization expense	$0	$87	'
Minimum [Member] | Patents trademarks and other [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'2 years	'	'
Minimum [Member] | Customer relationships [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'5 years	'	'
Minimum [Member] | Developed technology [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'5 years 6 months	'	'
Maximum [Member] | Patents trademarks and other [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'10 years	'	'
Maximum [Member] | Customer relationships [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'10 years	'	'
Maximum [Member] | Developed technology [Member]	'	'	'
Finite-Lived Intangible Assets [Abstract]	'	'	'
Finite-lived intangible assets, useful life	'10 years	'	'

Goodwill_and_Other_Intangible_5

Goodwill and Other Intangible Assets Acquisition Information (Details) (Lithicon AS [Member], USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 30, 2014	Feb. 05, 2014
Business Acquisition [Line Items]	'	'
Business Acquisition, Percentage of Voting Interests Acquired	'	100.00%
Acquisition Purchase Price	'	$68
Business Acquisition, Transaction Costs - Cumulative	0.4	'
Business Acquisition, Transaction Costs	0.3	'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net	'	7.7
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	'	22
Deferred Tax Assets, Goodwill and Intangible Assets	'	8.1
Acquisition related goodwill	'	46.4
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual	0.8	'
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual	1	'
Developed technology [Member]	'	'
Business Acquisition [Line Items]	'	'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	'	18.6
Customer relationships [Member]	'	'
Business Acquisition [Line Items]	'	'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	'	2.2
Order or Production Backlog [Member]	'	'
Business Acquisition [Line Items]	'	'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	'	$1.20

Warranty_Reserves_Details

Warranty Reserves (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Product Warranty Reserve Activity [Roll Forward]	'	'
Balance, beginning of period	$12,705	$12,049
Reductions for warranty costs incurred	-2,779	-3,403
Warranties issued	3,333	3,788
Translation and changes in estimates	5	-154
Balance, end of period	$13,264	$12,280

Income_Taxes_Net_Deferred_Tax_

Income Taxes - Net Deferred Tax Assets (Details) (USD $)	Mar. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Deferred Income Taxes [Abstract]	'	'
Deferred tax assets - current	$9,884	$15,114
Deferred tax assets - noncurrent	4,261	1,751
Deferred tax liabilities - current	-53	-9
Deferred tax liabilities - noncurrent	-11,465	-8,931
Net deferred tax assets (liabilities)	2,627	7,925
Valuation allowance	$4,514	$2,723

Income_Taxes_Unrecognized_Tax_

Income Taxes - Unrecognized Tax Benefits (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Income Tax Contingency [Line Items]	'	'
Unrecognized Tax Benefits, Period Increase (Decrease)	$0.10	$0.40
Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions	$0.20	'
United States [Member]	'	'
Income Tax Contingency [Line Items]	'	'
Tax years open for examination, by major tax jurisdiction	'2010	'
The Netherlands [Member]	'	'
Income Tax Contingency [Line Items]	'	'
Tax years open for examination, by major tax jurisdiction	'2011	'
Czech Republic [Member]	'	'
Income Tax Contingency [Line Items]	'	'
Tax years open for examination, by major tax jurisdiction	'2011	'

RelatedParty_Activity_Details

Related-Party Activity (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Related Party Transaction [Line Items]	'	'
Product sales to related parties	$1,089	$3,621
Service sales to related parties	261	153
Total sales to related parties	1,350	3,774
Purchases from related parties	447	25
Applied Materials [Member]	'	'
Related Party Transaction [Line Items]	'	'
Product sales to related parties	959	3,492
Service sales to related parties	168	133
Oregon Health and Science University [Member]	'	'
Related Party Transaction [Line Items]	'	'
Product sales to related parties	130	129
Service sales to related parties	82	9
Purchases from related parties	39	0
Lattice Semiconductor [Member]	'	'
Related Party Transaction [Line Items]	'	'
Service sales to related parties	3	3
Cascade Microtech [Member]	'	'
Related Party Transaction [Line Items]	'	'
Service sales to related parties	8	8
TMC BV [Member]	'	'
Related Party Transaction [Line Items]	'	'
Purchases from related parties	$408	$25

RelatedParty_Activity_Schedule

Related-Party Activity - Schedule of Amounts Due From (To) Related Parties (Details) (USD $)	Mar. 30, 2014
In Thousands, unless otherwise specified
Related Party Transaction [Line Items]	'
Due from (to) related party	$680
Applied Materials [Member]	'
Related Party Transaction [Line Items]	'
Due from (to) related party	990
Cascade Microtech [Member]	'
Related Party Transaction [Line Items]	'
Due from (to) related party	8
Oregon Health and Science University [Member]	'
Related Party Transaction [Line Items]	'
Due from (to) related party	-28
TMC BV [Member]	'
Related Party Transaction [Line Items]	'
Due from (to) related party	($290)

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (Inventories [Member], USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 30, 2014
Inventories [Member]	'
Unrecorded Unconditional Purchase Obligation [Line Items]	'
Non-cancelable purchase orders	$107.90
Purchase commitment, maximum expiration date	'second quarter of 2016

Segment_Information_Sales_to_E

Segment Information - Sales to External Customers and Gross Profit (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Segment Reporting Information [Line Items]	'	'
Sales to external customers	$226,264	$221,189
Gross profit	106,324	102,551
Industry [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Sales to external customers	106,437	99,064
Gross profit	56,132	50,514
Science [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Sales to external customers	119,827	122,125
Gross profit	$50,192	$52,037

Segment_Information_Goodwill_a

Segment Information - Goodwill and Total Assets (Details) (USD $)	Mar. 30, 2014	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Segment Reporting Information [Line Items]	'	'	'	'
Goodwill	$184,260	$136,152	$128,172	$131,320
Total Assets	1,477,600	1,426,084	'	'
Industry [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Goodwill	99,688	51,532	'	'
Total Assets	401,073	297,987	'	'
Science [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Goodwill	84,572	84,620	'	'
Total Assets	361,215	365,571	'	'
Intersegment Eliminations [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Total Assets	$715,312	$762,526	'	'

Restructuring_Reorganization_R2

Restructuring, Reorganization, Relocation and Severance (Details) (USD $)	3 Months Ended				6 Months Ended		3 Months Ended
	Mar. 30, 2014	Mar. 31, 2013	Mar. 30, 2014	Dec. 31, 2012	Jun. 30, 2013	Mar. 30, 2014	Mar. 30, 2014	Mar. 30, 2014	Mar. 31, 2013
			Group Structure Reorganization [Member]	Group Structure Reorganization [Member]	Group Structure Reorganization [Member]	First Quarter 2014 Restructuring Plan [Member]	First Quarter 2014 Restructuring Plan [Member]	Group Structure Reorganization [Member]	Group Structure Reorganization [Member]
Restructuring Cost and Reserve [Line Items]	'	'	'	'	'	'	'	'	'
Actual savings anticipated by restructuring activity	'	'	'	'	'	$1,800,000	'	'	'
Restructuring, reorganization, relocation and severance	1,331,000	695,000	'	2,900,000	1,100,000	'	1,331,000	0	695,000
Restructuring Reserve [Roll Forward]	'	'	'	'	'	'	'	'	'
Beginning accrued liability	50,000	2,692,000	'	'	'	'	0	50,000	2,692,000
Charged to expense, net	1,331,000	695,000	'	2,900,000	1,100,000	'	1,331,000	0	695,000
Expenditures	-484,000	-511,000	'	'	'	'	-484,000	0	-511,000
Write-offs and adjustments	'	-80,000	'	'	'	'	'	'	-80,000
Ending accrued liability	897,000	2,796,000	'	'	'	'	847,000	50,000	2,796,000
Expected additional cost of restructuring plan	'	'	0	'	'	'	'	'	'
Expected total cost of restructuring plan	'	'	'	'	$4,000,000	'	'	'	'

Fair_Value_of_Assets_and_Liabi

Fair Value of Assets and Liabilities - Securities (Details) (Fair Value, Measurements, Recurring [Member], USD $)	Mar. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Estimate of Fair Value, Fair Value Disclosure [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Equity securities - mutual funds	$6,254	$5,287
Derivative contracts, net	-2,936	-1,113
Assets, fair value	178,636	154,356
Estimate of Fair Value, Fair Value Disclosure [Member] | U.S. Government-backed securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	15,092	10,128
Estimate of Fair Value, Fair Value Disclosure [Member] | Agency bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	52,967	37,961
Estimate of Fair Value, Fair Value Disclosure [Member] | Commercial paper [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	34,989	39,987
Estimate of Fair Value, Fair Value Disclosure [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	8,578	7,786
Estimate of Fair Value, Fair Value Disclosure [Member] | Municipal Bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	51,601	49,319
Estimate of Fair Value, Fair Value Disclosure [Member] | Corporate Bond Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	12,091	5,001
Fair Value, Inputs, Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Equity securities - mutual funds	6,254	5,287
Derivative contracts, net	0	0
Assets, fair value	21,346	15,415
Fair Value, Inputs, Level 1 [Member] | U.S. Government-backed securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	15,092	10,128
Fair Value, Inputs, Level 1 [Member] | Agency bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 1 [Member] | Commercial paper [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 1 [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 1 [Member] | Municipal Bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 1 [Member] | Corporate Bond Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Equity securities - mutual funds	0	0
Derivative contracts, net	-2,936	-1,113
Assets, fair value	157,290	138,941
Fair Value, Inputs, Level 2 [Member] | U.S. Government-backed securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 2 [Member] | Agency bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	52,967	37,961
Fair Value, Inputs, Level 2 [Member] | Commercial paper [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	34,989	39,987
Fair Value, Inputs, Level 2 [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	8,578	7,786
Fair Value, Inputs, Level 2 [Member] | Municipal Bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	51,601	49,319
Fair Value, Inputs, Level 2 [Member] | Corporate Bond Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	12,091	5,001
Fair Value, Inputs, Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Equity securities - mutual funds	0	0
Derivative contracts, net	0	0
Assets, fair value	0	0
Fair Value, Inputs, Level 3 [Member] | U.S. Government-backed securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 3 [Member] | Agency bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 3 [Member] | Commercial paper [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 3 [Member] | Certificates of deposit [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 3 [Member] | Municipal Bonds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	0	0
Fair Value, Inputs, Level 3 [Member] | Corporate Bond Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Available for sale marketable securities	$0	$0

Derivative_Instruments_Details

Derivative Instruments (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Dec. 31, 2013
Derivative [Line Items]	'	'
Total outstanding derivative contracts	$335,908	$381,393
Outstanding derivative contracts maturity, maximum	'2 years	'
Cash Flow Hedging [Member]	'	'
Derivative [Line Items]	'	'
Total outstanding derivative contracts	177,397	208,446
Balance Sheet Hedges [Member]	'	'
Derivative [Line Items]	'	'
Total outstanding derivative contracts	$158,511	$172,947

Derivative_Instruments_Balance

Derivative Instruments - Balance Sheet Location (Details) (Foreign Exchange Contract [Member], USD $)	Mar. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Other Current Assets [Member]	'	'
Offsetting Derivative Assets [Abstract]	'	'
Gross Amounts of Recognized Assets	$720	$2,171
Gross Amounts Offset in the Balance Sheet	-275	-698
Net Amounts Presented in Other Current Assets	445	1,473
Other Current Liabilities [Member]	'	'
Offsetting Derivative Liabilities [Abstract]	'	'
Gross Amounts of Recognized Liabilities	6,079	7,278
Gross amounts offset in the balance sheet	-2,698	-4,692
Net Amounts Presented in Other Current Liabilities	3,381	2,586
Designated as Hedging Instrument [Member] | Other Current Assets [Member]	'	'
Offsetting Derivative Assets [Abstract]	'	'
Gross Amounts of Recognized Assets	0	0
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts Presented in Other Current Assets	0	0
Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]	'	'
Offsetting Derivative Liabilities [Abstract]	'	'
Gross Amounts of Recognized Liabilities	3,876	4,362
Gross amounts offset in the balance sheet	-2,065	-3,042
Net Amounts Presented in Other Current Liabilities	1,811	1,320
Not Designated as Hedging Instrument [Member] | Other Current Assets [Member]	'	'
Offsetting Derivative Assets [Abstract]	'	'
Gross Amounts of Recognized Assets	720	2,171
Gross Amounts Offset in the Balance Sheet	-275	-698
Net Amounts Presented in Other Current Assets	445	1,473
Not Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]	'	'
Offsetting Derivative Liabilities [Abstract]	'	'
Gross Amounts of Recognized Liabilities	2,203	2,916
Gross amounts offset in the balance sheet	-633	-1,650
Net Amounts Presented in Other Current Liabilities	$1,570	$1,266

Derivative_Instruments_Effect_

Derivative Instruments - Effect on Income Statement (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Foreign currency (loss) gain, inclusive of the impact of derivatives	($230)	($599)
Foreign Exchange Contract [Member] | Other Comprehensive Income (Loss) [Member] | Cash Flow Hedging [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Recognized in OCI (effective portion)	-2,202	-1,799
Foreign Exchange Contract [Member] | Sales Revenue, Net [Member] | Cash Flow Hedging [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Reclassified from accumulated OCI into cost of sales (effective portion)	37	0
Foreign Exchange Contract [Member] | Cost of Sales [Member] | Cash Flow Hedging [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Reclassified from accumulated OCI into cost of sales (effective portion)	-570	-297
Foreign Exchange Contract [Member] | Other Income Expense Net [Member] | Not Designated as Hedging Instrument [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Recognized in other, net	3,109	767
Foreign Exchange Contract [Member] | Other Income Expense Net [Member] | Cash Flow Hedging [Member]	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Recognized in other, net (ineffective portion and amount excluded from effectiveness testing)	$0	($25)

Changes_in_Accumulated_Other_C2

Changes in Accumulated Other Comprehensive Income by Component (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 30, 2014	Mar. 31, 2013
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'
Beginning balance	$47,128	$38,556
Other comprehensive income before reclassifications	-629	-17,647
Cost of goods sold	-119,940	-118,638
Other income (expense)	-270	-1,505
Net current period other comprehensive income	-96	-17,325
Ending balance	47,032	21,231
Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'
Revenues	-37	'
Cost of goods sold	570	297
Other income (expense)	0	25
Total reclassification out of AOCI	533	322
Accumulated Translation Adjustment [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'
Beginning balance	48,865	38,890
Other comprehensive income before reclassifications	107	-15,714
Net current period other comprehensive income	107	-15,714
Ending balance	48,972	23,176
Accumulated Translation Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'
Cost of goods sold	0	0
Other income (expense)	0	0
Total reclassification out of AOCI	0	0
Accumulated Net Unrealized Investment Gain (Loss) [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'
Beginning balance	-11	4
Other comprehensive income before reclassifications	1	7
Net current period other comprehensive income	1	7
Ending balance	-10	11
Accumulated Net Unrealized Investment Gain (Loss) [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'
Cost of goods sold	0	0
Other income (expense)	0	0
Total reclassification out of AOCI	0	0
Accumulated Defined Benefit Plans Adjustment [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'
Beginning balance	-552	-819
Other comprehensive income before reclassifications	16	-15
Net current period other comprehensive income	16	-15
Ending balance	-536	-834
Accumulated Defined Benefit Plans Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'
Cost of goods sold	0	0
Other income (expense)	0	0
Total reclassification out of AOCI	0	0
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'
Beginning balance	-1,174	481
Other comprehensive income before reclassifications	-753	-1,925
Net current period other comprehensive income	-220	-1,603
Ending balance	-1,394	-1,122
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]	'	'
Revenues	-37	'
Cost of goods sold	570	297
Other income (expense)	0	25
Total reclassification out of AOCI	$533	$322